Q301--Natera Signatera ctDNA Analysis for RIVAL Research Study
ID: 36C24E25Q0026Type: Special Notice
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFRPO EAST (36C24E)PITTSBURGH, PA, 15212, USA

NAICS

Medical Laboratories (621511)

PSC

MEDICAL- LABORATORY TESTING (Q301)
Timeline
  1. 1
    Posted Jan 24, 2025, 12:00 AM UTC
  2. 2
    Updated Jan 24, 2025, 12:00 AM UTC
  3. 3
    Due Jan 31, 2025, 4:59 PM UTC
Description

The Department of Veterans Affairs, specifically the Regional Procurement Office - East, intends to negotiate a sole-source contract with Natera, Inc. for conducting circulating tumor DNA (ctDNA) analysis as part of the RIVAL research study, which focuses on immunotherapy in veterans with locally advanced non-small cell lung cancer (NSCLC). The contract will support the analysis of ctDNA levels in approximately 40 patients at various VA medical centers, evaluating changes pre- and post-chemotherapy combined with immunotherapy to predict patient outcomes. Natera's Signatera assay is critical for this study due to its proven sensitivity and specificity, ensuring consistent analysis across baseline and follow-up samples. Interested parties must notify the Contracting Officer, Ms. Millicent Covert, at millicent.covert@va.gov by January 31, 2025, to express their interest and capabilities, as this notice is not a solicitation for competitive proposals.

Point(s) of Contact
Ms. Millicent CovertContracting Officer
(Calls shall not be accepted)
millicent.covert@va.gov
Files
Title
Posted
Jan 24, 2025, 10:04 PM UTC
The Veterans Health Administration's Regional Procurement Office - East is issuing a special notice regarding a sole-source contract with Natera, Inc. to conduct circulating tumor DNA (ctDNA) analysis for approximately 40 patients involved in the RIVAL research study, which focuses on immunotherapy in veterans with locally advanced non-small cell lung cancer (NSCLC). This study evaluates ctDNA levels pre- and post-chemotherapy combined with immunotherapy to predict patient outcomes. Natera’s Signatera assay, utilized for baseline and follow-up samples, is critical for the study due to its approved sensitivity and specificity, ensuring consistent analysis across samples. The contract period spans the base year plus two optional years. All sampling will occur at designated VA medical centers and results will be sent to the VA Ann Arbor Healthcare System. Notably, this notice is not a solicitation for competitive proposals but invites interested parties to express their capabilities by the specified deadline for potential procurement decisions. The document underscores the importance of using the same ctDNA analysis platform to maintain data integrity for the ongoing research efforts.
Lifecycle
Title
Type
Special Notice
Similar Opportunities
6630--Notice of Intent to Sole Source OC-AUTO SENSOR Diana FIT ANALYZER
Buyer not available
The Department of Veterans Affairs (VA) intends to negotiate a sole source delivery order with Polymedco for the OC-Sensor Diana FIT Analyzer, which is essential for maintaining the operation of its colon cancer screening program. This procurement is necessary to replace an expiring analyzer under an existing Business Partner Agreement, ensuring uninterrupted laboratory services for processing colon cancer screening specimens. The expected award date for this contract is March 15, 2025, and interested parties can direct inquiries to Contracting Officer Peter Park at Peter.Park2@va.gov. This notice serves to fulfill public dissemination requirements and is not a solicitation for competitive proposals.
6550--Lab Testing Services - (HIV/HCV/HPV/On)
Buyer not available
The Department of Veterans Affairs is seeking to negotiate a sole-source contract with Roche Diagnostics Corporation for lab testing services related to HIV, HCV, and HPV at the Corporal Michael J. Crescenz VA Medical Center. The contractor will be responsible for providing FDA-approved laboratory systems, instruments, maintenance, and consumables necessary for clinical testing, including a fully automated PCR testing platform with advanced features for real-time detection and minimal maintenance. This procurement is crucial for ensuring the delivery of quality healthcare services to veterans through efficient laboratory solutions. Interested parties must express their interest or submit capabilities by February 13, 2025, and can contact Contract Specialist Yazmin Alvarez at yazmin.alvarez@va.gov or 302-944-2511 x5202 for further information.
6550--Reagents and consumables
Buyer not available
The Department of Veterans Affairs (VA) is seeking qualified vendors to provide reagents and consumables for the VA Greater Los Angeles Healthcare System under solicitation number 36C26225Q0514. This procurement aims to support next-generation sequencing testing, requiring specific reagents compatible with Ion Torrent systems for analyzing myeloid and solid tumor DNA and RNA, as detailed in the attached Statement of Work. The selected contractor will play a crucial role in enhancing healthcare services through advanced genomic testing capabilities, ensuring compliance with VA policies and security protocols. Proposals are due by February 27, 2025, at 9:00 AM PST, and interested parties should direct inquiries to Carlos Magana at carlos.magana@va.gov.
Q527--Y90 TheraSpheres OY3
Buyer not available
The Department of Veterans Affairs (VA) is issuing a Special Notice for a sole source procurement of Y90 TheraSpheres from Boston Scientific Corporation, aimed at extending an existing contract for an additional two years. This procurement involves the delivery of various calibrated doses of TheraSpheres, which are critical for specific medical treatments within the Veterans Health Administration (VHA). Interested parties are invited to express their interest and capabilities by February 28, 2025, although this notice does not constitute a request for competitive quotations; the decision for competitive procurement will depend on the responses received. For further inquiries, interested vendors should contact Contract Specialist Mariangie Rios Vazquez at mariangie.riosvazquez@va.gov or by phone at 210-996-8816.
DA10--Corrective Action Reported for Compliance Notice of Intent to Sole Source Base and Option Years Concerning RFQ 36C25922Q0359
Buyer not available
The Department of Veterans Affairs (VA) is planning to award a sole source contract to Becton, Dickinson and Company for software and maintenance services related to the FACSLyric Flow Cytometry System. This procurement includes the FACSLink Base Software, interface connection licenses, middleware implementation, and ongoing maintenance support, extending from June 10, 2022, through June 9, 2026. The proprietary nature of the software necessitates that only the manufacturer, Becton Dickinson, can provide the required support and maintenance, highlighting the importance of reliable supplier relationships in health services. Interested parties are invited to express their capabilities and interest by February 28, 2025, and should contact Contract Specialist Phoebe Farmer at Phoebe.Farmer@va.gov or 405-456-3685 for further information.
Notice of Intent to Sole Source to Extend Services for N6264520P0020 - Molecular Assay-Analyzers
Buyer not available
The Department of Defense, through the Defense Health Agency (DHA), intends to issue a sole source bridge contract to BioFire Defense, LLC for the provision of a molecular diagnostic laboratory analyzer, along with necessary assays, reagents, and consumables at Naval Hospital Camp Pendleton and Naval Medical Center Portsmouth. The contract, which is set to run from April 16, 2025, to October 15, 2025, with an option for an additional six months, requires the analyzer to perform a variety of tests using polymerase chain reaction (PCR) technology, including respiratory, blood culture, gastrointestinal, and meningitis/encephalitis assays, while ensuring compliance with FDA regulations. This procurement is critical for maintaining effective diagnostic capabilities within military medical facilities, and interested vendors must submit capability statements by February 28, 2025, as the procurement will not be open for competitive proposals. For further inquiries, vendors can contact Margaret Suever at margaret.a.suever.civ@health.mil or by phone at 210-952-8283.
7A21--Circle Cardiovascular Imaging CVi42
Buyer not available
The Department of Veterans Affairs (VA) intends to award a firm-fixed price contract to Circle Cardiovascular Imaging Inc. for the provision of services related to their proprietary cvi42 product line, which includes various subscriptions for advanced cardiac imaging services. The required services encompass Cardiac MR, Core CT with Auto Plaque, 4DFlow, Strain, Quantitative Perfusion, and Advanced Reporting, covering a base year and two option years. This procurement is critical for enhancing the VA's cardiac imaging capabilities, as the cvi42 product is uniquely positioned in the market, with Circle Cardiovascular Imaging asserting sole manufacturing rights. Interested parties are invited to submit capability statements by February 27, 2025, to the primary contact, Gillian M. Hooge, at gillian.hooge@va.gov or by phone at (210) 364-3724, as the agency will proceed with the contract if no other comparable sources are identified within seven days.
6550--VISN 19 Multi-Facility Point-of-Care New PNT/INR Assays Cost Per Kit (CPK)
Buyer not available
The Department of Veterans Affairs (VA) is seeking vendors for point-of-care (POC) PT/INR assay services under Solicitation Number 36C25925Q0220, aimed at enhancing healthcare delivery across multiple facilities in VISN 19. The procurement involves the supply of analyzers, reagents, and necessary equipment, including 11 analyzers for the Rocky Mountain Regional VA Medical Center, 15 for the Oklahoma City VA Health Care System, and 17 devices for the Salt Lake City VA Health Care System, along with additional support equipment. This initiative is crucial for providing timely and accurate diagnostic services to veterans, ensuring compliance with federal regulations and maintaining high standards of care. Interested parties must respond by February 27, 2025, to Contracting Officer Lindsey Zwaagstra at Lindsey.Zwaagstra@va.gov or by phone at 303-712-5733, as this notice serves to gauge market interest and vendor capabilities rather than a formal request for quotes.
6640--FY25: Automated Immunochemical Fecal Occult Blood Test (IFOBT)
Buyer not available
The Department of Veterans Affairs is seeking to award a sole-source contract for the provision of Automated Immunochemical Fecal Occult Blood Test (IFOBT) reagents, specifically targeting the Orlando Healthcare System. This procurement is in accordance with federal regulations that permit sole-source contracts under certain conditions, emphasizing the need for specialized testing reagents critical for patient diagnostics. Interested vendors capable of fulfilling this requirement are encouraged to submit a complete technical package by February 27, 2025, at 1:00 PM EST, to the Contract Specialist, Benjamin Amato, at Benjamin.Amato@va.gov. This opportunity aims to identify potential sources for future related procurements, although the government will not provide compensation for any information submitted.
Q301--Biodesix, Inc. (621 II) (PENDING PROPOSAL)
Buyer not available
The Department of Veterans Affairs is soliciting proposals for reference laboratory services under the Federal Supply Schedule (FSS) program, specifically for medical laboratory testing related to disease diagnosis and patient health assessment. The procurement aims to establish contracts for services that comply with federal, state, and local regulations, including necessary licensing and accreditation, while ensuring that only new items are provided and that grey market goods are strictly prohibited. This opportunity is critical for enhancing the quality of healthcare services provided to veterans, with a focus on compliance with the Trade Agreements Act and other regulatory requirements. Interested vendors should contact Contract Specialist Brian O'Connell at Brian.O'connell@va.gov for further details, and they must adhere to the submission deadlines outlined in the solicitation documents.